Dergi makalesi Açık Erişim
Kolukisa, Burcu; Baser, Dilek; Akcam, Bengu; Danielson, Jeffrey; Eltan, Sevgi Bilgic; Haliloglu, Yesim; Sefer, Asena Pinar; Babayeva, Royale; Akgun, Gamze; Charbonnier, Louis-Marie; Schmitz-Abe, Klaus; Demirkol, Yasemin Kendir; Zhang, Yu; Gonzaga-Jauregui, Claudia; Heredia, Raul Jimenez; Kasap, Nurhan; Kiykim, Ayca; Yucel, Esra Ozek; Gok, Veysel; Unal, Ekrem; Unal, Ekrem
{ "DOI": "10.1111/all.15010", "abstract": "Background Biallelic loss-of-function mutations in CARMIL2 cause combined immunodeficiency associated with dermatitis, inflammatory bowel disease (IBD), and EBV-related smooth muscle tumors. Clinical and immunological characterizations of the disease with long-term follow-up and treatment options have not been previously reported in large cohorts. We sought to determine the clinical and immunological features of CARMIL2 deficiency and long-term efficacy of treatment in controlling different disease manifestations. Methods The presenting phenotypes, long-term outcomes, and treatment responses were evaluated prospectively in 15 CARMIL2-deficient patients, including 13 novel cases. Lymphocyte subpopulations, protein expression, regulatory T (Treg), and circulating T follicular helper (cT(FH)) cells were analyzed. Three-dimensional (3D) migration assay was performed to determine T-cell shape. Results Mean age at disease onset was 38 +/- 23 months. Main clinical features were skin manifestations (n = 14, 93%), failure to thrive (n = 10, 67%), recurrent infections (n = 10, 67%), allergic symptoms (n = 8, 53%), chronic diarrhea (n = 4, 27%), and EBV-related leiomyoma (n = 2, 13%). Skin manifestations ranged from atopic and seborrheic dermatitis to psoriasiform rash. Patients had reduced proportions of memory CD4(+) T cells, Treg, and cT(FH) cells. Memory B and NK cells were also decreased. CARMIL2-deficient T cells exhibited reduced T-cell proliferation and cytokine production following CD28 co-stimulation and normal morphology when migrating in a high-density 3D collagen gel matrix. IBD was the most severe clinical manifestation, leading to growth retardation, requiring multiple interventional treatments. All patients were alive with a median follow-up of 10.8 years (range: 3-17 years). Conclusion This cohort provides clinical and immunological features and long-term follow-up of different manifestations of CARMIL2 deficiency.", "author": [ { "family": "Kolukisa", "given": " Burcu" }, { "family": "Baser", "given": " Dilek" }, { "family": "Akcam", "given": " Bengu" }, { "family": "Danielson", "given": " Jeffrey" }, { "family": "Eltan", "given": " Sevgi Bilgic" }, { "family": "Haliloglu", "given": " Yesim" }, { "family": "Sefer", "given": " Asena Pinar" }, { "family": "Babayeva", "given": " Royale" }, { "family": "Akgun", "given": " Gamze" }, { "family": "Charbonnier", "given": " Louis-Marie" }, { "family": "Schmitz-Abe", "given": " Klaus" }, { "family": "Demirkol", "given": " Yasemin Kendir" }, { "family": "Zhang", "given": " Yu" }, { "family": "Gonzaga-Jauregui", "given": " Claudia" }, { "family": "Heredia", "given": " Raul Jimenez" }, { "family": "Kasap", "given": " Nurhan" }, { "family": "Kiykim", "given": " Ayca" }, { "family": "Yucel", "given": " Esra Ozek" }, { "family": "Gok", "given": " Veysel" }, { "family": "Unal", "given": " Ekrem" }, { "family": "Unal", "given": " Ekrem" } ], "container_title": "ALLERGY", "id": "235246", "issue": "3", "issued": { "date-parts": [ [ 2022, 1, 1 ] ] }, "page": "1004-1019", "title": "Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency", "type": "article-journal", "volume": "77" }
Görüntülenme | 47 |
İndirme | 4 |
Veri hacmi | 1.5 kB |
Tekil görüntülenme | 46 |
Tekil indirme | 4 |